US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
US20030139588A9
(en)
*
|
1998-10-13 |
2003-07-24 |
Ruoping Chen |
Endogenous and non-endogenous versions of human G protein-coupled receptors
|
US7208280B2
(en)
|
1999-10-05 |
2007-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
JP2004508843A
(ja)
*
|
2000-09-22 |
2004-03-25 |
ケムコム エス.エー. |
嗅覚及びフェロモンのgタンパク質共役型受容体
|
WO2002064793A2
(en)
*
|
2001-01-03 |
2002-08-22 |
Curagen Corporation |
G protein-coupled receptor-like proteins and nucleics acids encoding same
|
WO2003004992A2
(en)
|
2001-07-03 |
2003-01-16 |
The Regents Of The University Of California |
Mammalian sweet and amino acid heterodimeric taste receptors
|
EP1523308A4
(en)
|
2001-07-20 |
2007-01-10 |
Us Gov Health & Human Serv |
PHENYL THIOCARBAMIDE (PTC) TREATMENT RECEPTOR
|
US20030096751A1
(en)
*
|
2001-08-20 |
2003-05-22 |
Ramanathan Chandra S. |
G-protein coupled receptor polynucleotides and methods of use thereof
|
GB0208407D0
(en)
*
|
2001-10-01 |
2002-05-22 |
Aventis Pharma Inc |
A novel G protein-coupled receptor, GAVE10
|
CA2463553A1
(en)
*
|
2001-10-12 |
2003-04-17 |
The Regents Of The University Of California |
Gastrointestinal chemosensory receptors
|
EP1474176A4
(en)
*
|
2001-11-26 |
2005-06-15 |
Bristol Myers Squibb Co |
HUMAN G PROTEIN-COUPLED RECEPTOR, HGPRBMY31, VARIANTS AND METHODS OF USING THE SAME
|
US20030232359A1
(en)
*
|
2002-03-18 |
2003-12-18 |
Ramanathan Chandra S. |
Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY40_2
|
PT1553980E
(pt)
*
|
2002-04-01 |
2012-01-19 |
Agensys Inc |
Ácido nucleico e proteína correspondente intitulada 238p1b2 útil no tratamento e detecção do cancro
|
US20040016004A1
(en)
|
2002-04-01 |
2004-01-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer
|
US20030196212A1
(en)
*
|
2002-04-10 |
2003-10-16 |
Jian Zhang |
Novel pheromone receptor
|
US7141381B2
(en)
|
2002-04-25 |
2006-11-28 |
Bristol-Myers Squibb Company |
Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
|
WO2004071393A2
(en)
*
|
2003-02-13 |
2004-08-26 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with glucagon-like peptide 1 receptor (glp1r)
|
WO2004081170A2
(en)
*
|
2003-03-10 |
2004-09-23 |
Ares Trading S.A. |
Progestin receptor-like protein
|
EP1603585A2
(en)
|
2003-03-14 |
2005-12-14 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
|
WO2005007891A2
(en)
*
|
2003-06-19 |
2005-01-27 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Variants of human taste receptor genes
|
US20050106571A1
(en)
|
2003-10-02 |
2005-05-19 |
The Regents Of The University Of California |
Mammalian T1R3 sweet taste receptors
|
DK1693456T3
(da)
*
|
2003-11-19 |
2011-03-21 |
Daiichi Sankyo Co Ltd |
Fremgangsmåde til identificering af modulatorer af en G-protein-koblet receptor
|
US7527937B2
(en)
*
|
2003-11-19 |
2009-05-05 |
Daiichi Sankyo Company, Limited |
Assay employing a g-protein coupled receptor that is activated by CCK-8S
|
US7189539B2
(en)
|
2003-11-25 |
2007-03-13 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a human relaxin receptor, HGPRBMY5v1
|
WO2005080973A1
(en)
|
2004-02-13 |
2005-09-01 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human nuclear receptor nr5a1 (nr5a1)
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
CA2606489A1
(en)
*
|
2005-05-02 |
2006-11-09 |
Daiichi Sankyo Company, Limited |
Method for identification of compound having antidepressant effect
|
US20100029702A1
(en)
*
|
2006-11-02 |
2010-02-04 |
Daisuke Okajima |
Method For Identification of Compound Having Anti-Anxiety Effect
|
JP5486928B2
(ja)
|
2007-02-26 |
2014-05-07 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックウレアおよびカルバメートインヒビター
|
CA2697168A1
(en)
|
2007-07-26 |
2009-02-05 |
Vitae Pharmaceuticals, Inc. |
Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
WO2009075835A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
JP5490020B2
(ja)
|
2008-01-24 |
2014-05-14 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
|
WO2009102428A2
(en)
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
JP5730021B2
(ja)
|
2008-02-15 |
2015-06-03 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体
|
EP2291373B1
(en)
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
NZ588954A
(en)
|
2008-05-01 |
2012-08-31 |
Vitae Pharmaceuticals Inc |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8592410B2
(en)
|
2008-05-01 |
2013-11-26 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
|
CL2009001058A1
(es)
|
2008-05-01 |
2010-09-10 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
|
ES2432150T3
(es)
|
2008-07-25 |
2013-12-02 |
Boehringer Ingelheim International Gmbh |
Inhibidores cíclicos de la 11 beta-hidroxiesteroide deshidrogenasa 1
|
TW201016691A
(en)
|
2008-07-25 |
2010-05-01 |
Boehringer Ingelheim Int |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8637505B2
(en)
|
2009-02-04 |
2014-01-28 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8680093B2
(en)
|
2009-04-30 |
2014-03-25 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2011011123A1
(en)
|
2009-06-11 |
2011-01-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
IL199618A0
(en)
*
|
2009-06-29 |
2010-04-29 |
Two To Biotech Ltd |
Novel antibodies and their use in diagnostic methods
|
JP5749263B2
(ja)
|
2009-07-01 |
2015-07-15 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
US20110237461A1
(en)
|
2010-03-17 |
2011-09-29 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
JP5860042B2
(ja)
|
2010-06-16 |
2016-02-16 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
|
WO2011161128A1
(en)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
EA201300522A1
(ru)
|
2010-11-02 |
2013-11-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Фармацевтические комбинации для лечения метаболических нарушений
|
SG10201701547VA
(en)
*
|
2011-02-23 |
2017-03-30 |
Massachusetts Inst Technology |
Water soluble membrane proteins and methods for the preparation and use thereof
|
WO2014114303A1
(en)
*
|
2013-01-22 |
2014-07-31 |
Deutsches Zentrum Für Neurodegenerative Erkrankungen |
Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
|
DK2948777T3
(da)
*
|
2013-01-22 |
2019-09-23 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Dipeptid-repeat-proteiner som terapeutisk mål i neurodegenerative sygdomme med hexanukleotid-repeat-udvidelse
|
US10373702B2
(en)
|
2014-03-27 |
2019-08-06 |
Massachusetts Institute Of Technology |
Water-soluble trans-membrane proteins and methods for the preparation and use thereof
|
SG10201913625XA
(en)
|
2015-08-07 |
2020-03-30 |
Imaginab Inc |
Antigen binding constructs to target molecules
|
WO2018147960A1
(en)
|
2017-02-08 |
2018-08-16 |
Imaginab, Inc. |
Extension sequences for diabodies
|
WO2023230578A2
(en)
*
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating circulating factors
|
WO2023230566A2
(en)
*
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating cytokines
|
WO2023230570A2
(en)
*
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating genetic drivers
|
WO2024040033A2
(en)
*
|
2022-08-15 |
2024-02-22 |
The Regents Of The University Of California |
Multi-chain synthetic receptors for simultaneous ligand‑induced transcriptional regulation and membrane‑proximal signal transduction
|